Delivery Order SPE2DB20D2014-SPE2DB25FD01R
- Not listed
- The Defense Logistics Agency awarded a $2,415.13 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose 5-gram packets. The contract employs firm fixed pricing with no set-aside designation, reflecting a competitive award to the pharmaceutical distributor. The order is scheduled for completion by September 4, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $1,185.93 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The order is scheduled for completion by September 18, 2025, and will be fulfilled from the contractor's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose 5-gram packages, with a contract ceiling value of $1,262.22. This firm fixed price delivery order is expected to be completed by September 12, 2025, and represents a non-set-aside, competitively awarded transaction. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $1,428.90 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages on September 11, 2025, with completion scheduled for September 12, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside restrictions, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose packets of 5 grams. This competitively awarded, non-set-aside contract carries a ceiling value of $1,493.80 and represents a firm fixed-price delivery order with an ultimate completion date of August 5, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Testosterone 50 mg/5 gram packets (unit dose, 5 grams) with a ceiling value of $1,010.68. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order is scheduled for ultimate completion by August 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $2,802.75 delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packets. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, representing a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania, with a completion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose packets of 5 grams, with a ceiling value of $2,219.70 and a firm fixed price structure. This delivery order, which represents the ultimate completion date of September 12, 2025, was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award falls...
- The Defense Logistics Agency awarded a delivery order valued at $1,224.76 to AmerisourceBergen Drug Corp for the supply of Testosterone 1% (50 mg/5 g) in unit dose 5-gram packages. The award was made on September 5, 2025, with an ultimate completion date of September 8, 2025, under a firm fixed-price contract type with no set-aside designation. Performance will be executed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,183.65 to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Testosterone 1% (25mg/2.5g) in unit dose packaging. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 25, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the open competitive procurement process....
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FD01RDelivery Order
The Defense Logistics Agency awarded a $2,765.20 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose packets of 5 grams. The contract represents a firm fixed price delivery order with no set-aside designation, reflecting competitive award terms. Performance will be completed at AmerisourceBergen's Conshohocken, Pennsylvania facility by September 17, 2025. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a prime pharmaceutical vendor, AmerisourceBergen serves as a critical supplier to the Defense Health Agency and broader military healthcare systems, providing a comprehensive range of pharmaceuticals, medical devices, and healthcare commodities to support federal medical procurement needs worldwide. The company's role in the DLA's pharmaceutical supply chain demonstrates its established capability to fulfill federal healthcare requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 9/16/25 |